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ABSTRACT 
Identification of early indicators of di-
agnosis and prognosis together with 
tight control of disease activity are the 
current goals of management of early 
arthritis.
Several studies in the literature to date 
suggest that musculoskeletal ultra-
sonography (US) may have a role in 
this setting. US is a valid and reliable 
tool for the assessment of inflammatory 
arthritis – either as an ultra-sensitive 
measure of inflammation or joint dam-
age. US is also useful in the differential 
diagnosis of early arthritis, both identi-
fying disease specific findings and inte-
grating clinical findings into structured 
diagnostic algorithms. Grey scale and 
power Doppler US are sensitive disease 
activity and severity markers, identify-
ing subgroups of patients with poorer 
clinical and radiological outcomes, 
even once clinical remission has been 
achieved.
The present review provides an update 
of the available data and discusses re-
search issues of ultrasound imaging in 
early arthritis.
Introduction
Early arthritis is a clinical entity which 
includes classifiable and undifferenti-
ated arthritides. 
It is vital to make early diagnosis and 
aim towards tight control of disease ac-
tivity in order to modify the course of 
rheumatoid arthritis (RA) (1, 2).
Musculoskeletal ultrasound (US) is well 
established as a useful imaging modal-
ity in different types of inflammatory 
arthritis (IA) (3). Most of the published 
work centres upon established RA but 
in recent years there has been increas-
ing focus on the early phases of RA and 
undifferentiated synovitis.
The present review deals with the 
potential application of US in the as-
sessment of patients with early IA.
Is US useful in the early 
detection of synovitis?
US has become an important diagnostic 
tool in the assessment of rheumatolog-
ic diseases, as it can accurately detect a 
number of elementary lesions including 
joint effusion, synovial hypertrophy, 
tenosynovitis, enthesopathy, bursitis, 
bone erosions and cartilage abnormali-
ties (4-7).
These properties make US an invalu-
able tool in the diagnosis of early IA. 
The first way in which US can assist 
the clinician in making diagnosis of IA 
is by allowing the patient with non-spe-
cific hand and/or wrist pain to be dif-
ferentiated from the patient with true 
synovitis.
US has been shown to compare favour-
ably with several other imaging tech-
niques, including contrast-enhanced 
MRI, arthroscopy, scintigraphy, and 
histology in the detection of synovitis 
(8, 9). In a study examining a cohort of 
patients with early RA, US was found to 
be even more useful than MRI at iden-
tifying joint and tendon sheath effusion 
(10). When compared with clinical ex-
amination US demonstrates higher sen-
sitivity in detecting synovitis in both 
longstanding and early RA (4). This 
seems particularly useful in discrimi-
nating oligo-arthritis from polyarthritis, 
with obvious prognostic implications, 
especially in the setting of an early as-
sessment (11, 12). 
The addition of power Doppler (PD) 
to conventional gray scale (GS) US 
allows assessment of soft tissue vascu-
larity (13, 14). PD has been validated 
against MRI and histology, and was 
proven to identify active synovitis in 
RA (15-17). 
392
IMAGING Role of US imaging in early arthritis / C.A. Scirè et al.
Is US useful in early detection 
of joint damage?
There is overwhelming evidence that 
the high resolution and multi-planar 
properties of US scanning can sen-
sitively detect erosions, even before 
plain radiography. We are also aware 
that US performs well compared with 
computerised tomography (CT) as a 
gold standard for bone erosion detec-
tion. From the analysis performed on 
metacarpophalangeal joints (MCP) of 
erosive RA patients, US was more sen-
sitive than conventional radiography 
(42% vs. 19%) and also highly specific 
(91%) (18).
Several studies have documented that 
US depicts erosions up to 6 times as 
much as x-rays in early RA patients 
(19-22). However, no increased sen-
sitivity was reported in two cross sec-
tional studies (10,23). These differenc-
es may relate to the different resolution 
of the US equipment employed and to 
the different joints assessed. In spite of 
this the reliability of US in the detec-
tion of erosions is now well established 
(24) and the accuracy appears to de-
pend on the acoustic window of indi-
vidual joints, being maximal for the1st, 
2nd, 5th MCP and 1st and 5th metatar-
sophalangeal joints (MTP).
More recently, Bajaj et al. prospec-
tively investigated US bone erosions 
at the 2nd, 5th MCP, 5th MTP and the 
2 most involved proximal interphalan-
geal joints (PIP) in early RA, confirm-
ing a higher sensitivity compared with 
plan radiography and detection of bone 
damage by US before it became evident 
on x-rays (25). This property will make 
US an invaluable tool for the detection 
of bony erosions in early RA (Fig. 1) 
(21, 26).
Cartilage damage can also be quanti-
fied by US in early RA as well as in 
established RA and osteoarthritis (27).
Is US useful in the differential 
diagnosis of early IA? 
Freeston et al. proposed a diagnostic al-
gorithm which includes US for the pre-
diction of persistent arthritis in patients 
presenting with IA from less than 12 
weeks. This study showed clear benefit 
of GS and PD US particularly in seroneg-
ative patients, in which the prediction of 
persistence clinically is much more dif-
ficult because of the absence of defined 
prognostic factors. In this subgroup the 
presence of US features such as a high 
GS score , PD signal and at least one US 
erosion increased the probability of per-
sistent IA from 30% to 94%, while if US 
features were absent, the probability felt 
to 0-5%.(28)
US is able to clearly depict entheseal 
pathology and would appear to be a 
valid tool for the discrimination be-
tween spondyloarthropathies and RA 
(29-31). Whilst this is an area requiring 
more research, sub-clinical entheseal 
inflammation detected by US could 
identify those patients with psoriasis 
and an increased risk to develop psori-
atic arthritis (32).
Several studies have demonstrated the di-
agnostic utility of US in the diagnosis of 
crystal-associated arthropathies (7, 33).
It is clear that much additional research 
needs to be done in the area of disease 
differentiation in early IA and that US 
findings are only relevant when coupled 
with clinical parameters.
Invasive US guided techniques such as 
joint fluid aspiration and synovial biop-
sies may be useful in the early diagnosis 
of IA. Furthermore US-guided injection 
may assist in the accurate delivery of 
drug therapy to joints and tendon sheaths 
(34). US-guided mini-invasive biopsy 
procedures can now be performed in 
both large and small joints and may add 
valuable information to the assessment 
of early IA (35, 36).
Is US scan a reliable tool for  
disease activity and severity 
assessment in early IA?
Semi-quantitative grading systems 
(grade 0-3) have been generally applied 
to all joints investigated with US to date 
(13, 14, 37) Using this technique an 
overall US score can be obtained using 
the sum of the grade of each investigat-
ed joint. A gathering body of evidence 
supports the validity and reliability of 
such measures in early IA.
In early RA Naredo et al. showed a sig-
nificant correlation between DAS28, 
CRP and PD scores (assessed at 28 
joints) throughout the clinical course of 
patients recently commenced onto dis-
ease modifying drugs and a correlation 
between persistent PD signal and the 
Fig. 1. US shows 
an erosion of the 
lateral aspect of 
the fifth metatar-
sophalangeal joint 
(A) in a patient 
with early rheuma-
toid arthritis, while 
conventional radio-
graphy fails to im-
age the same lesion 
(B).
For further ul-
trasound images, 
go to www.clinex-
prheumatol.org/
ultrasound
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progression of radiographic damage 
(38). A significant correlation with ESR 
and CRP has been recently reported 
in a larger cohort of early RA both for 
GS and PD assessed in 44 joints (39). 
Correlation between US measures and 
inflammatory indices was significant 
even if patients with early undifferenti-
ated IA were included (40).
As for the number and pattern of the 
joints to be scanned, several simpli-
fied joint counts have been proposed 
to avoid time consuming extensive 
examinations (41-43). Further applica-
tions of a systematic assessment by US 
pointed toward the prediction and the 
assessment of the response to treatment 
in early IA. 
The effectiveness of intramuscular 
steroids was tested in 102 patients with 
recent-onset inflammatory hand pain. 
In this study the predictive value of 
clinical, laboratory and US variables 
was evaluated. A significant association 
with clinical response to intramuscular 
steroids was found only for US-prov-
en synovitis and presence of rheuma-
toid factor, whilst clinical synovitis or 
raised CRP were not predictive. Such 
results indicate that an objective meas-
ure of inflammation in early IA can 
drive the therapeutic decision towards 
the right way (44). 
In patients with erosive early RA rand-
omized to receive methotrexate plus in-
fliximab or methotrexate plus placebo, 
the quantification of PD in the MCP 
joints was predictive of progression of 
radiographic erosion after 12 months in 
the placebo group (45). This study pro-
vided evidence of a modification of both 
grey scale and PD synovitis according to 
clinical response to therapy and a more 
profound suppression of US signs of in-
flammation in the infliximab group. 
A recent study has shown that modifi-
cation of US characters was lower than 
that of standard clinical measures, such 
as manual joint count in early IA (46). 
Can US identify sub-clinical 
joint inflammation and ongoing 
structural damage in early IA? 
A considerable body of evidence exists 
in support of the application of US in 
the assessment of residual disease ac-
tivity. The majority of RA patients in 
clinical remission show signs of per-
sistent inflammation on US scanning 
at the wrists and MCPs (41, 47). It is 
well recognised that some patients with 
RA in clinical remission still have ra-
diographic progression. Brown et al. 
have investigated the predictive value 
of sub-clinical inflammation in terms 
of radiographic progression. This study 
clearly indicated that the patients with 
PD signal in clinical remission had 
the highest risk of progressive joint 
damage (48). 
Analyzing a smaller group of patients 
with early RA in clinical remission, it 
has also been shown that the presence 
of sub-clinical inflammation detect-
ed by US may help in discriminating 
patients with short-lived or unstable 
clinical remission. In particular these 
patients with PD positive synovitis 
showed a significantly increased risk 
of early relapse compared with PD 
negative (39). 
Research agenda and conclusions
US is a valuable imaging tool in early 
IA where a very sensitive and highly 
reproducible analysis of joint inflam-
mation is particularly required. Techni-
cal advances will further improve the 
resolution and the sensitivity of this 
technique. The introduction of three-
dimensional probes could also over-
come the operator dependence of US 
allowing for the standardized acquisi-
tion of images for reliable monitoring 
(21, 26, 49).
Further innovation includes fusion im-
aging, which conjugates different mo-
dalities, US and MRI, improving the 
diagnostic accuracy by highlighting 
strengths and weakening limitations of 
each imaging technique (50). 
Further study of sub-clinical disease 
might permit the differentiation of 
patients with different clinical enti-
ties: those with potentially favourable 
outcomes from those with a poor out-
come. There may also be merit in inte-
grating clinical and US findings in the 
decision making process of patients 
with early IA.
Link
For ultrasound images, go to www.
clinexprheumatol.org/ultrasound
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